POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy — Stella

Home/Acute Coronary Syndrome/

View on ClinicalTrials.gov

Recruiting

Back to Acute Coronary Syndrome trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Netherlands

St. Antonius Hospital, Nieuwegein, Utrecht

Key details

Phase

Safety & dosing

Sponsor

St. Antonius Hospital

Enrollment target

~200 participants

Started

July 2023

Primary completion

June 2026

Age range

18 Years and older

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.